These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36594446)

  • 1. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
    Yang R; Tang J; Kuang M; Liu H
    Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities.
    Yang R; Tang J; Zhuo Y; Kuang M; Liu H
    Clin Exp Hypertens; 2022 Apr; 44(3):240-248. PubMed ID: 34974781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Oh A; Hiroi S; Takeshima T; Otsuka Y; Iwasaki K; Shimasaki Y
    Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.
    Ishida T; Oh A; Hiroi S; Shimasaki Y; Tsuchihashi T
    Clin Exp Hypertens; 2019; 41(3):203-210. PubMed ID: 29781721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria.
    Adejumo O; Okaka E; Iyawe I
    Malawi Med J; 2017 Jun; 29(2):113-117. PubMed ID: 28955417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of prescription and rationality of anti-hypertensive medication among community health centers in Beijing].
    Bai JJ; Zhang WL; Wang L; Liu PY; Cai J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):993-999. PubMed ID: 34674437
    [No Abstract]   [Full Text] [Related]  

  • 7. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C; Luedde M; Kostev K
    JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
    Hiroi S; Shimasaki Y; Kikuchi T; Otsuka Y; Iwasaki K; Ohishi M
    Hypertens Res; 2016 Dec; 39(12):907-912. PubMed ID: 27465576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018.
    Hou W; Li D; Shen S; Lin J; Lou A; Wen A
    Clin Ther; 2021 Mar; 43(3):602-612. PubMed ID: 33637331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive treatment for hypertensive patients with heart failure using real-world Japanese data: subanalysis of the Retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Nishigaki N; Oh A; Shimasaki Y
    Clin Exp Hypertens; 2020; 42(2):139-145. PubMed ID: 30912679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drugs for elderly patients: a cross- sectional study.
    Lim KK; Sivasampu S; Khoo EM
    Singapore Med J; 2015 May; 56(5):291-7. PubMed ID: 25597751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.
    Ibaraki A; Goto W; Iura R; Tominaga M; Tsuchihashi T
    Hypertens Res; 2017 Feb; 40(2):203-206. PubMed ID: 27581534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of hypertension treatment in Belgium, a pharmacoepidemiological study.
    Wolf M; Heuten HG; De Swaef A; de Falleur M; Verpooten GA
    Acta Cardiol; 2012 Apr; 67(2):147-52. PubMed ID: 22641971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.
    Kim HL; Hwang D; Lee JH; Lee HY; Ihm SH; Kim KI; Shin J; Park S; Kim DH; Sung KC
    Hypertens Res; 2022 May; 45(5):758-768. PubMed ID: 35338336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
    Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
    BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive drug treatment changes in the general population: the CoLaus study.
    Christe V; Waeber G; Vollenweider P; Marques-Vidal P
    BMC Pharmacol Toxicol; 2014 Mar; 15():20. PubMed ID: 24685255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
    Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.